APA (7th ed.) Citation

RN, B., CN, E., IS, Y., SJ, H., AB, A., & PM, B. (2014). The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial. Journal of diabetes and its complications, 28(3), 323. https://doi.org/10.1016/j.jdiacomp.2014.01.001

Chicago Style (17th ed.) Citation

RN, Black, Ennis CN, Young IS, Hunter SJ, Atkinson AB, and Bell PM. "The Peroxisome Proliferator-activated Receptor Alpha Agonist Fenofibrate Has No Effect on Insulin Sensitivity Compared to Atorvastatin in Type 2 Diabetes Mellitus; a Randomised, Double-blind Controlled Trial." Journal of Diabetes and Its Complications 28, no. 3 (2014): 323. https://doi.org/10.1016/j.jdiacomp.2014.01.001.

MLA (9th ed.) Citation

RN, Black, et al. "The Peroxisome Proliferator-activated Receptor Alpha Agonist Fenofibrate Has No Effect on Insulin Sensitivity Compared to Atorvastatin in Type 2 Diabetes Mellitus; a Randomised, Double-blind Controlled Trial." Journal of Diabetes and Its Complications, vol. 28, no. 3, 2014, p. 323, https://doi.org/10.1016/j.jdiacomp.2014.01.001.